|
LOC647859 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.53649999999584E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.552600E-04 |
| Normal-vs-Stage2 |
1.081950E-02 |
| Normal-vs-Stage3 |
8.464300E-03 |
| Normal-vs-Stage4 |
2.059700E-02 |
| Stage1-vs-Stage2 |
2.823600E-01 |
| Stage1-vs-Stage3 |
7.922000E-01 |
| Stage1-vs-Stage4 |
6.715800E-01 |
| Stage2-vs-Stage3 |
2.436400E-01 |
| Stage2-vs-Stage4 |
5.319600E-01 |
| Stage3-vs-Stage4 |
5.744000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.172380E-04 |
| Normal-vs-AfricanAmerican |
2.392300E-02 |
| Normal-vs-Asian |
9.624000E-01 |
| Caucasian-vs-AfricanAmerican |
6.424800E-01 |
| Caucasian-vs-Asian |
9.148100E-02 |
| AfricanAmerican-vs-Asian |
2.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.24390000000452E-05 |
| Normal-vs-Female |
4.902300E-03 |
| Male-vs-Female |
2.730600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.478300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.959000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.223540E-04 |
| Normal-vs-Age(81-100Yrs) |
2.593600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.132000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.850800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.977400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.036200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.766400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.940800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.618400E-02 |
| Normal-vs-Grade 2 |
7.191800E-04 |
| Normal-vs-Grade 3 |
3.045700E-04 |
| Normal-vs-Grade 4 |
1.498350E-01 |
| Grade 1-vs-Grade 2 |
1.594190E-01 |
| Grade 1-vs-Grade 3 |
2.884000E-01 |
| Grade 1-vs-Grade 4 |
6.257800E-02 |
| Grade 2-vs-Grade 3 |
5.798000E-01 |
| Grade 2-vs-Grade 4 |
4.041600E-02 |
| Grade 3-vs-Grade 4 |
1.625700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.121940E-03 |
| Normal-vs-ccB subtype |
3.659400E-03 |
| ccA subtype-vs-ccB subtype |
6.393800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.966800E-04 |
| Normal-vs-N1 |
9.681800E-01 |
| N0-vs-N1 |
4.023600E-02 |
|
|
